Novonesis | Sustainability Performance
Produces and markets industrial enzymes and microorganisms for various applications.
2000
Denmark
10,001+ employees
Biotechnology
$1B - 10B in revenue
$500M - 1B in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#11342
Overallⓘ#176
in Denmarkⓘ#236
in BiotechnologyⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon emissionsCarbon certificatesDigital emissionsEnergy consumptionWaste ManagementWater ManagementNature and biodiversitySocial
Diversity and InclusionHealth and SafetyExternalitiesGovernance
TargetsSDG Impact
Critical
Critical
Critical
Aligned
Intensity
Greenhouse gas intensity (Scope 1, 2, 3)(tCO₂e /$M)
Water consumption intensity (m³ /$M)
Industry Benchmark
347.2
B/M 128.6
391.6
B/M 102.0
Powered by illuminem and GIST Impact
Controversy level
- Novonesis (NovozymesChr Hansen merger January 2024 USD 12.3 billion), Danish global biosolutions major (enzymes, microbes), has faced sustained class actions over the contested 2024 USD 12.3 billion NovozymesChr Hansen merger integration challenges affecting Danish institutional shareholders, plus periodic EU Commission antitrust scrutiny over the contested 2023 merger antitrust review.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
11+
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.